- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-148/15: Judgment of the Court (First Chamber) of 19 October 2016 (request for a preliminary ruling from the Oberlandesgericht Düsseldorf — Germany) — Deutsche Parkinson Vereinigung eV v Zentrale zur Bekämpfung unlauteren Wettbewerbs eV (Reference for a preliminary ruling — Articles 34 TFEU and 36 TFEU — Free movement of goods — National legislation — Prescription-only medicinal products for human use — Sale by pharmacies — Setting of fixed prices — Quantitative restriction on imports — Measure having equivalent effect — Justification — Protection of the health and life of humans)
ECLI:EU:UNKNOWN:62015CA0148
62015CA0148
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 475/5
(Case C-148/15) (<span class="super note-tag">1</span>)
((Reference for a preliminary ruling - Articles 34 TFEU and 36 TFEU - Free movement of goods - National legislation - Prescription-only medicinal products for human use - Sale by pharmacies - Setting of fixed prices - Quantitative restriction on imports - Measure having equivalent effect - Justification - Protection of the health and life of humans))
(2016/C 475/06)
Language of the case: German
Referring court
Parties to the main proceedings
Applicant: Deutsche Parkinson Vereinigung eV
Defendant: Zentrale zur Bekämpfung unlauteren Wettbewerbs eV
Operative part of the judgment
1.Article 34 TFEU must be interpreted as meaning that national legislation, such as that at issue in the main proceedings, which provides for a system of fixed prices for the sale by pharmacies of prescription-only medicinal products for human use, constitutes a measure having equivalent effect to a quantitative restriction on imports, within the meaning of that article, since that legislation has a greater impact on the sale of prescription-only medicinal products by pharmacies established in other Member States than on the sale of the same medicinal products by pharmacies established within the national territory.
2.Article 36 TFEU must be interpreted as meaning that national legislation, such as that at issue in the main proceedings, which provides for a system of fixed prices for the sale by pharmacies of prescription-only medicinal products for human use, cannot be justified on grounds of the protection of health and life of humans, within the meaning of that article, inasmuch as that legislation is not appropriate for attaining the objectives pursued.
Language of the case: German
(<span class="note">1</span>) OJ C 213, 29.6.2015.